⌘K
Loading ticker…
As of 2026-08-21, Verrica Pharmaceuticals Inc. Common Stock (VRCA) has a 3-month relative strength percentile of 20 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.7%, relative volume 1.23×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
VRCA appears in 1 ETF as of May 2026: AVTM at 0.00% weight, $3K notional.
Held by 5 ETFs · $1M across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVTM | 0.00% | $3K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VRCA Jan avg: 5.57% median: -11.44% win: 25% σ: 42.09% n: 4 2022-04-12 → 2026-07-31 | VRCA Feb avg: 9.77% median: -3.25% win: 50% σ: 39.77% n: 4 2022-04-12 → 2026-07-31 | VRCA Mar avg: -9.74% median: -9.71% win: 25% σ: 18.79% n: 4 2022-04-12 → 2026-07-31 | VRCA Apr avg: 3.90% median: 4.98% win: 60% σ: 16.16% n: 5 2022-04-12 → 2026-07-31 | VRCA May avg: -11.92% median: -8.10% win: 40% σ: 35.25% n: 5 2022-04-12 → 2026-07-31 | VRCA Jun avg: 0.07% median: 1.76% win: 60% σ: 8.65% n: 5 2022-04-12 → 2026-07-31 | VRCA Jul avg: 9.44% median: 1.21% win: 60% σ: 31.65% n: 5 2022-04-12 → 2026-07-31 | VRCA Aug avg: -15.65% median: -11.36% win: 25% σ: 37.62% n: 4 2022-04-12 → 2026-07-31 (current) | VRCA Sep avg: -25.35% median: -24.24% win: 0% σ: 9.81% n: 4 2022-04-12 → 2026-07-31 | VRCA Oct avg: -9.92% median: -10.00% win: 0% σ: 6.49% n: 4 2022-04-12 → 2026-07-31 | VRCA Nov avg: 43.51% median: 15.26% win: 50% σ: 74.30% n: 4 2022-04-12 → 2026-07-31 | VRCA Dec avg: 7.38% median: -12.03% win: 25% σ: 63.06% n: 4 2022-04-12 → 2026-07-31 |